跳至主要内容
临床试验/NCT00334555
NCT00334555已完成不适用

Control of Trichomoniasis - A Paradigm for STD Control

University of Alabama at Birmingham2 个研究点 分布在 1 个国家目标入组 599 人开始时间: 2003年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
599
试验地点
2
主要终点
recurrence of trichomonas in the index patient

研究概览

简要总结

This study is designed to try to find the best method of partner notification and treatment for partners of women with trichomonas

详细描述

To carry out a randomized trial to compare the effectiveness of three methods of partner notification and treatment for sexual partners of women with vaginal trichomoniasis - patient self-referral of partners (the current practice standard), delivery of curative therapy to partners by patients themselves, or public health style Disease Intervention carried out by a specially trained Disease Intervention Specialists (DIS) locating the partners and delivering the medication in the field. Reinfection rates with trichomonas at three months of follow-up among the index women will be the measure of effectiveness.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion criteria {for Women}:
  • Age {> 15 years} Culture or wet prep proven T. vaginalis infection Willingness to provide informed consent and take part in study procedures

排除标准

  • Exclusion criteria:
  • Infection with other STD pathogens requiring Health Dept DIS intervention (syphilis or HIV) Pregnancy or currently breast feeding Recent (8 hours) ingestion of alcoholic beverages or intent to do so in the 24 hours following treatment Allergy to metronidazole The presence of a sexual partner in the clinic at the time of enrollment A history of referral by a partner already treated for trichomoniasis Report of more than four sexual partners in the preceding 30 days

结局指标

主要结局

recurrence of trichomonas in the index patient

时间窗: 6 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Control of Trichomoniasis | 临床试验